Zymeworks Inc. (ZYME) is a publicly traded Healthcare sector company. As of August 25, 2026, ZYME trades at $26.30 with a market cap of $2.05B and a P/E ratio of -6.91. ZYME moved -6.38% today. Year to date, ZYME is +9.27%; over the trailing twelve months it is +90.53%. Its 52-week range spans $9.03 to $29.75. Analyst consensus is strong buy with an average price target of $40.33. Rallies surfaces ZYME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ZYME insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $26.30 |
| Market Cap | $2.05B |
| P/E Ratio | -6.91 |
| EPS | $-4.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.75 |
| 52-Week Low | $9.03 |
| Volume | 981.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $31.62M |
| Net Income | $-236.97M |
| Gross Margin | 0.00% |
9 analysts cover ZYME: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.33.